| Authors: |
Neelapu SS; The University of Texas MD Anderson Cancer Center, Houston, TX., Chavez JC; Moffitt Cancer Center, Tampa, FL., Sehgal AR; UPMC Hillman Cancer Center, Pittsburgh, PA., Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Ulrickson ML; Banner MD Anderson Cancer Center, Gilbert, AZ., Bachy E; Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Munshi PN; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Casulo C; University of Rochester Medical Center, Wilmot Cancer Center, Rochester, NY., Maloney DG; Fred Hutchinson Cancer Center, Seattle, WA., de Vos S; Ronald Reagan University of California Los Angeles Medical Center, Santa Monica, CA., Reshef R; Columbia University Herbert Irving Comprehensive Cancer Center, New York City, NY., Leslie LA; John Theurer Cancer Center, Hackensack, NJ., Oluwole OO; Vanderbilt University Medical Center, Nashville, TN., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France., Khanal R; Fox Chase Cancer Center, Philadelphia, PA., Rosenblatt JD; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL., Wulff J; Kite, a Gilead Company, Santa Monica, CA., Shen RR; Kite, a Gilead Company, Santa Monica, CA., Zhang W; Kite, a Gilead Company, Santa Monica, CA., Poddar S; Kite, a Gilead Company, Santa Monica, CA., Miao H; Kite, a Gilead Company, Santa Monica, CA., Nikolajeva O; Kite, a Gilead Company, Santa Monica, CA., Jacobson CA; Dana-Farber Cancer Institute, Boston, MA. |
